Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1962-05

AUTHORS

W. M. HUNTER, F. C. GREENWOOD

ABSTRACT

RECENT procedures for the immunological assay of protein hormones in human plasma1–3 require the routine preparation of hormones labelled with iodine-131 of high specific activity.

PAGES

495-496

References to SciGraph publications

Journal

TITLE

Nature

ISSUE

4827

VOLUME

194

Related Patents

  • Antibodies Directed Against Programmed Death-1 (Pd-1)
  • Nucleotide Sequences Coding Polypeptide For Use In The Treatment And Prevention Of Infections, Inflammation, Allergenic, Lung, Skin And Cancer Disorders
  • Anti-Cd151 Antibodies And Their Use In The Treatment Of Cancer
  • Compositions And Methods For Cancer
  • Methods For Producing Humanized Antibodies And Improving Yield Of Antibodies Or Antigen Binding Fragments In Cell Culture
  • Dna Encoding A Soluble Vegf Inhibitor
  • Methods Of Screening For Trpm5 Modulators
  • Method Of Treating Pustular Psoriasis With Antibodies Directed Against Interleukin 36 Receptor (Il-36r)
  • Apo-2 Ligand
  • Assays For Detecting Antibodies Specific To Therapeutic Anti-Ige Antibodies And Their Use In Anaphylaxis
  • Antibodies Directed Against Lymphocyte Activation Gene 3 (Lag-3)
  • Antibodies Directed Against Interleukin-33 (Il-33) And Methods Of Making And Using
  • Antibodies To Dcr3 Polypeptide, A Tnfr Homolog
  • Idiotypic Antibodies Against Anti-Pd-L1 Antibodies And Uses Thereof
  • Induces Mammalian Cancer Cell Apoptosis; Used To Treat Cancer
  • Method For Efficient Delivery Of Therapeutic Molecules In Vitro And In Vivo
  • Compositions And Methods For Inhibiting Matrix Metalloproteinase (Mmp)-Mediated Cell Migration
  • Nipple Covering System
  • Constructs Targeting Afp Peptide/Mhc Complexes And Uses Thereof
  • Altered April Binding Antibodies
  • Antibodies Directed Against T Cell Immunoglobulin And Mucin Protein 3 (Tim-3)
  • Apo-2 Receptor Polypeptides
  • Cross-Screening System And Methods For Detecting A Molecule Having Binding Affinity For A Target Molecule
  • Solubility Forms; Skin Disorders, Rheumatic Disorders, Antidiabetic Agents
  • Ultrapurified Dsba And Dsbc And Methods Of Making And Using The Same
  • Smoothened Polypeptides For Binding Patched
  • Constructs Targeting Histone H3 Peptide/Mhc Complexes And Uses Thereof
  • Cdna Encoding A Gene Bog (B5t Over-Expressed Gene) And Its Protein Product
  • Detecting Amount Of Labelled Peptide Bound To Silk; Useful In Detecting Or Monitoring Alzheimer's Disease
  • Cd80 Variant Immunomodulatory Proteins And Uses Thereof
  • Antibodies To Apo-2 Receptor Polypeptides
  • Antibodies Directed Against Interleukin 36 Receptor (Il-36r)
  • Variants Of Vascular Endothelial Cell Growth Factor
  • Nucleic Acids Encoding Anti-Neonatal Fc Receptor (Fcrn) Antibodies
  • Apo-2 Ligand
  • Apo-2 Ligand
  • Novel Peptide Hormones With Calcitonin-Like Activity
  • Nucleic Acids Coding For Adhesion Factors Of Group B Streptococcus, Adhesion Factors Of Group B Streptococcus And Futher Uses Thereof
  • Compositions Comprising Purified Anti-Abeta Monoclonal Antibodies
  • Compositions And Methods For Cancer
  • Inhibitor Of Vascular Endothelial Cell Growth Factor
  • Anti-Htra1 Antibodies And Methods Of Use
  • Anti Cxcr4 Antibodies And Their Use For The Treatment Of Cancer
  • Hepatocyte Growth Factor Receptor Antagonist Antibodies And Uses Thereof
  • Cyclic Peptides And Methods Of Use Thereof
  • Used To Modulate P-Rb (Retinoblastoma Susceptibility Gene Product)-Protein Interactions, For Cancer Analysis And Treatment By Controlling Cell Growth And Proliferation
  • Systems And Methods For Breast Cancer Detection And Risk Assessment
  • Variants Of Vascular Endothelial Cell Growth Factor
  • Anti-Htra1 Antibodies And Methods Of Use Thereof
  • Apo-2-Receptor
  • Comprises Apoptosis Membrane Protein (Apo-2) And Monoclonal Antibody Antagonist For Treating Cancer, Cardiovascular And Nervous System Disorders
  • Compositions Comprising Purified Recombinant Il-13 Antibody
  • Apo-2 Receptor Polynucleotides
  • Cd80 Variant Immunomodulatory Proteins And Uses Thereof
  • Anti-Htra1 Antibodies And Methods Of Use Thereof
  • Fc Receptor Antibodies And Methods Of Use Thereof
  • Cd80 Variant Immunomodulatory Proteins And Uses Thereof
  • Method And Apparatus To Identify Vulnerable Plaques With Thermal Wave Imaging Of Heated Nanoparticles
  • Cd80 Variant Immunomodulatory Proteins And Uses Thereof
  • Anticancer Agent
  • Administering Osteopontin Antisense Oligonucleotide To Inhibit Expression
  • Ultrapurified Dsba And Dsbc And Methods Of Making And Using The Same
  • Methods For Stimulating Hematopoietic Progenitors Using Hepatocyte Growth Factor And Lymphokines
  • Restoration Of Vasculature After A Myocardial Infarct
  • Amino Acid Sequence Of Native Polypeptide Which Interacts With Hedgehog And Patched Signaling Molecules Involved In Cell Proliferation And Differentiation; For Therapy And Diagnosis
  • Apo-2 Ligand
  • Human And Rat Smoothened, Are Provided. Compositions Including Vertebrate Smoothened Chimeras, Nucleic Acid Encoding Vertebrate Smoothened, And Antibodies To Vertebrate Smoothened, Are Also Provided.
  • Cancer Treatment With C-Met Antagonists And Correlation Of The Latter With Hgf Expression
  • Method Of Enhancing Proliferation Or Differentiation Of Hematopoietic Stem Cells Using Wnt Polypeptides
  • Inhibiting C-Met Activation In Subject By Administering An Hgf/C-Met Antagonist Molecule, Wherein The Hgf/C-Met Antagonist Molecule Comprises An Hgf Mutant Comprising A Mutation In Hgf Beta Chain N Terminal Region, Wherein Mutation Is G498i, G498p, G498v, R502del Plus T503del, Or D672n
  • Antibodies To Muc16 And Methods Of Use Thereof
  • Method And Apparatus To Identify Vulnerable Plaques With Thermal Wave Imaging Of Heated Nanoparticles
  • Compositions And Methods For Detecting And Quantifying Host Cells Protein In Cell Lines And Recombinant Polypeptide Products
  • Anti-C-Met-Antibody Formulations
  • Detecting Variations In Mammalian Immunoglobulins; Obtain Immunoglobulins, Compare Variable Domains Of Immunoglobulins, Detect Homogeneity, Detect Variability In Sequence Complementarity Determining Region Of Immunoglobulins
  • Administering An Effective Amount Of Hepatocyte Growth Factor Receptor Antagonist To A Mammal Diagnosed As Having Cancer, Wherein Said Hepatocyte Growth Factor Receptor Antagonist Is An Antibody
  • Anti-Muc16 Antibodies And Uses Thereof
  • Apo-2 Ligand
  • Bispecific Antibody Constructs And Methods Of Use
  • O-Fucosyltransferase
  • Cd80 Variant Immunomodulatory Proteins And Uses Thereof
  • Hepatocyte Growth Factor Receptor Agonists And Uses Thereof
  • Methods And Compositions Comprising Purified Recombinant Polypeptides
  • Hepatocyte Growth Factor Receptor Antagonists And Uses Thereof
  • Methods Of Treating Cancer With Anti-Pd-1 Antibodies
  • Method Of Treating Inflammatory Disorder With Antibodies Directed Against Interleukin-33 (Il-33)
  • Idiotypic Antibodies And Uses Thereof
  • Apo-3 Polypeptide
  • Variants Of Vascular Endothelial Cell Growth Factor, Their Uses, And Processes For Their Production
  • Nucleic Acids Encoding Hepatocyte Growth Factor Receptor Antagonist Antibodies
  • Nucleic Acids Coding For Adhesion Factors Of Group B Streptococcus, Adhesion Factors Of Group B Streptococcus And Futher Uses Thereof
  • Methods And Compositions Comprising Purified Recombinant Polypeptides
  • Cd80 Variant Immunomodulatory Proteins And Uses Thereof
  • Uses Of Wnt Polypeptides
  • Affinity Enhancement Immunological Reagents For In Vivo Detection And Killing Of Specific Target Cells
  • Nipple Covering System
  • Method Of Treatment Comprising Purified Recombinant Il-13 Antibody
  • Hgf Β Chain Variants
  • Immunoglobulins Which Bind Preferential Mammalian Polypeptide; For The Treatment Of Cancer; Anticarcinogenic Agents
  • Cd80 Variant Immunomodulatory Proteins And Uses Thereof
  • Conjugates Of Alliinase With A Protein Carrier That Targets The Alliinase To Specific Cells Are Used In Combination With Alliin To Produce Allicin At A Desired Target Site To Kill Cancer Cells Or Pathogens.
  • Anti-Cxcr4 Antibodies And Their Use For The Treatment Of Cancer
  • Icos Ligand Variant Immunomodulatory Proteins And Uses Thereof
  • Compositions And Methods In Cancer Associated With Altered Expression Of Kcnj9
  • Humanized Antibodies Which Bind To Human April (“A Proliferation-Inducing Ligand”)
  • Humanized Anti Cxcr4 Antibodies For The Treatment Of Cancer
  • Antibodies Directed Against T Cell Immunoglobulin And Mucin Protein 3 (Tim-3)
  • Non-Small Cell Lung, Colon, Colorectal, Lymphoma, Pancreatic Or Ovarian Cancer
  • Anti-Bv8 Antibodies And Uses Thereof
  • Inhibitor Of Vascular Endothelial Cell Growth Factor
  • Methods For Detection Of Breast Cancer
  • Formation Of Preferential Amyloid Plaques; Obtain Amyloid Proteins, Incubate With Sulfated Macromolecule, Stain With Congo Red And Evaluate Staining Pattern With Transmission Electron Microscopy
  • Flt4 (Vegfr-3) As A Target For Tumor Imaging And Anti-Tumor Therapy
  • Apo-2 Receptor Agonist Antibodies
  • Chimeric Fibroblast Growth Factors With Altered Receptor Specificity
  • Binding Members For Human C-Maf
  • Magneto-Motive Ultrasound Detection Of Magnetic Nanoparticles
  • Method Of Treatment Comprising Purified Recombinant Il-13 Antibody
  • Compositions And Methods In Cancer Associated With Altered Expression Of Prlr
  • Hgf Β Chain Variants
  • Compositions And Methods For Detecting And Quantifying Host Cell Protein In Cell Lines And Recombinant Polypeptide Products
  • Using Hepatocyte Growth Factor And Protein
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/194495a0

    DOI

    http://dx.doi.org/10.1038/194495a0

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1006221676

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/14450081


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "author": [
          {
            "affiliation": {
              "alternateName": "Division of Chemistry and Biochemistry, Imperial Cancer Research Fund, Lincoln's Inn Fields, W.C.2, London", 
              "id": "http://www.grid.ac/institutes/grid.11485.39", 
              "name": [
                "Division of Chemistry and Biochemistry, Imperial Cancer Research Fund, Lincoln's Inn Fields, W.C.2, London"
              ], 
              "type": "Organization"
            }, 
            "familyName": "HUNTER", 
            "givenName": "W. M.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Chemistry and Biochemistry, Imperial Cancer Research Fund, Lincoln's Inn Fields, W.C.2, London", 
              "id": "http://www.grid.ac/institutes/grid.11485.39", 
              "name": [
                "Division of Chemistry and Biochemistry, Imperial Cancer Research Fund, Lincoln's Inn Fields, W.C.2, London"
              ], 
              "type": "Organization"
            }, 
            "familyName": "GREENWOOD", 
            "givenName": "F. C.", 
            "id": "sg:person.0105721045.60", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0105721045.60"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/1901211a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052322294", 
              "https://doi.org/10.1038/1901211a0"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1962-05", 
        "datePublishedReg": "1962-05-01", 
        "description": "RECENT procedures for the immunological assay of protein hormones in human plasma1\u20133 require the routine preparation of hormones labelled with iodine-131 of high specific activity.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/194495a0", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "4827", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "194"
          }
        ], 
        "keywords": [
          "human growth hormone", 
          "growth hormone", 
          "iodine-131", 
          "protein hormones", 
          "hormone", 
          "immunological assays", 
          "high specific activity", 
          "specific activity", 
          "routine preparation", 
          "recent procedure", 
          "activity", 
          "assays", 
          "procedure", 
          "preparation"
        ], 
        "name": "Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity", 
        "pagination": "495-496", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1006221676"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/194495a0"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "14450081"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/194495a0", 
          "https://app.dimensions.ai/details/publication/pub.1006221676"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:47", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_87.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/194495a0"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/194495a0'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/194495a0'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/194495a0'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/194495a0'


     

    This table displays all metadata directly associated to this object as RDF triples.

    77 TRIPLES      20 PREDICATES      39 URIs      32 LITERALS      7 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/194495a0 schema:author N5131a3d7161947d294dbbf20bc1e0474
    2 schema:citation sg:pub.10.1038/1901211a0
    3 schema:datePublished 1962-05
    4 schema:datePublishedReg 1962-05-01
    5 schema:description RECENT procedures for the immunological assay of protein hormones in human plasma1–3 require the routine preparation of hormones labelled with iodine-131 of high specific activity.
    6 schema:genre article
    7 schema:isAccessibleForFree false
    8 schema:isPartOf N1fdfdcc4de664b7fa1bc9195b556f4fc
    9 N87ff175507f94701b4c7925c1345c8ef
    10 sg:journal.1018957
    11 schema:keywords activity
    12 assays
    13 growth hormone
    14 high specific activity
    15 hormone
    16 human growth hormone
    17 immunological assays
    18 iodine-131
    19 preparation
    20 procedure
    21 protein hormones
    22 recent procedure
    23 routine preparation
    24 specific activity
    25 schema:name Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
    26 schema:pagination 495-496
    27 schema:productId N24d0edf571ed4750807b93ff33bcfaec
    28 N877b59f69dae4962b957052aa99c36a6
    29 Nedcb3eae646e4fb895c211e9fa2ae57c
    30 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006221676
    31 https://doi.org/10.1038/194495a0
    32 schema:sdDatePublished 2022-10-01T06:47
    33 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    34 schema:sdPublisher N3f0afbb49d25411da7235755478c8997
    35 schema:url https://doi.org/10.1038/194495a0
    36 sgo:license sg:explorer/license/
    37 sgo:sdDataset articles
    38 rdf:type schema:ScholarlyArticle
    39 N1fdfdcc4de664b7fa1bc9195b556f4fc schema:volumeNumber 194
    40 rdf:type schema:PublicationVolume
    41 N24d0edf571ed4750807b93ff33bcfaec schema:name doi
    42 schema:value 10.1038/194495a0
    43 rdf:type schema:PropertyValue
    44 N3f0afbb49d25411da7235755478c8997 schema:name Springer Nature - SN SciGraph project
    45 rdf:type schema:Organization
    46 N5131a3d7161947d294dbbf20bc1e0474 rdf:first Nfdbb494a97dc4cd49c62cf2286da9fca
    47 rdf:rest Nffbf3da75156467790dc775438be3897
    48 N877b59f69dae4962b957052aa99c36a6 schema:name dimensions_id
    49 schema:value pub.1006221676
    50 rdf:type schema:PropertyValue
    51 N87ff175507f94701b4c7925c1345c8ef schema:issueNumber 4827
    52 rdf:type schema:PublicationIssue
    53 Nedcb3eae646e4fb895c211e9fa2ae57c schema:name pubmed_id
    54 schema:value 14450081
    55 rdf:type schema:PropertyValue
    56 Nfdbb494a97dc4cd49c62cf2286da9fca schema:affiliation grid-institutes:grid.11485.39
    57 schema:familyName HUNTER
    58 schema:givenName W. M.
    59 rdf:type schema:Person
    60 Nffbf3da75156467790dc775438be3897 rdf:first sg:person.0105721045.60
    61 rdf:rest rdf:nil
    62 sg:journal.1018957 schema:issn 0028-0836
    63 1476-4687
    64 schema:name Nature
    65 schema:publisher Springer Nature
    66 rdf:type schema:Periodical
    67 sg:person.0105721045.60 schema:affiliation grid-institutes:grid.11485.39
    68 schema:familyName GREENWOOD
    69 schema:givenName F. C.
    70 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0105721045.60
    71 rdf:type schema:Person
    72 sg:pub.10.1038/1901211a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052322294
    73 https://doi.org/10.1038/1901211a0
    74 rdf:type schema:CreativeWork
    75 grid-institutes:grid.11485.39 schema:alternateName Division of Chemistry and Biochemistry, Imperial Cancer Research Fund, Lincoln's Inn Fields, W.C.2, London
    76 schema:name Division of Chemistry and Biochemistry, Imperial Cancer Research Fund, Lincoln's Inn Fields, W.C.2, London
    77 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...